News
They have been called miraculous and the fastest way to lose weight. From Wegovy to Mounjaro, here’s how GLP-1 drugs work ...
Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...
Despite their benefits, there are a number of things to consider before taking weight loss drugs – including possible ...
Innovent announces phase 3 study of mazdutide in Chinese adults with overweight or obesity (GLORY-1) published in the NEJM: San Francisco, US Tuesday, May 27, 2025, 11:00 Hrs [IST ...
GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.
Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...
A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.
The study targets adults in China with overweight or obesity accompanied metabolic dysfunction-associated fatty liver disease (MAFLD ... of mazdutide versus semaglutide in Chinese adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results